协合生物集团成立于1988年，历经30多年的发展，依托太空生物技术、超级抗原技术和基因工程技术，中药提纯技术致力于健康产品的研发和生产。
协合生物集团拥有国家批准成立的博士后科研工作站和院士科研工作站；承担四项国家火炬计划项目，连续入选国家十一五、十二五重点国家项目的研究，是国家科技部火炬中心认定的重点高新技术企业。
协合生物集团荟萃了百余名国内外知名院士、专家和学者，是国内同时拥有院士科研工作站和博士后科研工作站的企业之一。
开拓进取的协合人秉承“生物科技达天下，超级抗原惠万家”的企业理念，不断向社会传播“预防大于治疗”等健康理念，让更多的人认识到超级抗原是唤醒自身免疫的原动力。协合人倡导“科技报国”、“向上、向善、向真、向爱”的企业文化。
走进协合，拥抱健康，传播大爱！品质第一，诚信为本，愿协合产品普惠大众健康。
Founded in 1988, Xiehe Biology Group has been developing for 38 years.
Relying on space biotechnology, superantigen technology and genetic engineering technology, Xiehe Biology Group is committed to the research and development of medical and health products. Its globally exclusive superantigen series of biological products have made universally recognized achievements in the prevention and treatment of major diseases such as cancer, AIDS, leukemia and bone diseases.
Pioneering staff of Xiehe Group have been adhering to the corporate philosophy of "Xiehe Health for the World, Biotech for Every Home". Xiehe has focused on the research and development of superantigen products and has continuously spread to the society healthcare concepts such as "autoimmunity is the best doctor, prevention is more than treatment", so that more people can realize that superantigens are the motive force for awakening auto-immunity.
协合目标
全球免疫科技领航者
协合精神
诚信、敬业、务实、创新
协合愿景
生物科技达天下
超级抗原惠万家
协合使命
构建人类免疫屏障
促进全民身心健康
协合文化
向上、向善、向真、向爱
